mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.003 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.005 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.006 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.006 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.007 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.009 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |